𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition

✍ Scribed by Stephan Lang; Sanjay Tiwari; Michaela Andratschke; Iren Loehr; Lina Lauffer; Christoph Bergmann; Brigitte Mack; Annette Lebeau; Andreas Moosmann; Theresa L. Whiteside; Reinhard Zeidler

Book ID
105967233
Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
397 KB
Volume
56
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

COX-2 polymorphisms and the risk for hea
COX-2 polymorphisms and the risk for head and neck cancer in white patients
✍ Wilbert H. M. Peters; Martin Lacko; Rene H. M. te Morsche; Adri C. Voogd; Michae πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract ## __Background.__ Cyclooxygenase‐2 (COX‐2) is an enzyme involved in the synthesis of prostaglandins and thromboxanes, which are regulators of processes such as inflammation, cell proliferation, and angiogenesis, all relevant for cancer development. We investigated whether functional g

Cell-mediated immune response in head an
Cell-mediated immune response in head and neck cancer patients
✍ Dr. A. Olivari; R. Pradier; J. Feierstein; A. Guardo; H. Glait; A. Rojas πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 381 KB

## Abstract The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts. DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with m